Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-01-06

EMA Authorised: Spedra (avanafil) — Menarini International Operations Luxembourg S.A.

View source ↗

Summary

The European Medicines Agency authorised Spedra (avanafil) for erectile dysfunction, with marketing authorisation holder Menarini International Operations Luxem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spedra (avanafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Menarini International Operations Luxembourg S.A.. Decision date: 05/01/2026